PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
09-May-2020 Lilly Receives U.S. FDA Approval for Retevmo(TM) (selpercatinib), the First Therapy Specifically for Patients with Advanced RET-Driven Lung and Thyroid Cancers Eli Lilly and Company
08-May-2020 AbbVie Completes Transformative Acquisition of Allergan AbbVie
08-May-2020 Biotest AG: Annual General Meeting approves dividend distribution Biotest AG
08-May-2020 HJB and Mabspace Biosciences' Development and Manufacturing Agreement for Novel Humanized Claudin18.2 Monoclonal Antibody Accomplished FDA and NMPA IND Clearance HJB
08-May-2020 MOLOGEN AG: Sale of the essential assets MOLOGEN AG
08-May-2020 Immunic, Inc. Reports First Quarter 2020 Financial Results and Highlights Recent Activity Immunic, Inc.
08-May-2020 Biotest AG: Biotest increases sales by 26% Biotest AG
08-May-2020 Biotest AG: Biotest increases sales by 26% Biotest AG
07-May-2020 Prescryptive Health and Bartell Drugs Partner to Expand Access to Reliable, Safe and Secure COVID-19 Testing Prescryptive Health
07-May-2020 Trovagene Announces First Quarter 2020 Results and Highlights Trovagene, Inc.
07-May-2020 Nektar Therapeutics Reports First Quarter 2020 Financial Results Nektar Therapeutics
07-May-2020 Apotex Corp. Resolves US Federal Government Antitrust Investigation Regarding Generic Drug Pricing Apotex Corp.
07-May-2020 Strata Oncology and Collaborators to Present Data at ASCO 2020 Strata Oncology, Inc.
07-May-2020 Lawmakers Take Steps to Decriminalize Psychedelic Mushrooms FinancialBuzz.com
07-May-2020 Lawmakers Take Steps to Decriminalize Psychedelic Mushrooms FinancialBuzz.com
07-May-2020 Magic Mushroom Advocates Seek to Emulate the Rise of CBD FinancialBuzz.com
07-May-2020 Wize Pharma Completes Phase IV Study of LO2A for the Treatment of Dry Eye Syndrome in Patients with Sjögren's Syndrome Wize Pharma, Inc.
07-May-2020 Covid-19 Volunteer Testing Network scaling up - delivering tests for GPs and care home workers Sciad Newswire
06-May-2020 Tyvyt® (Sintilimab Injection) Combined with Gemzar® (Gemcitabine for Injection) and Platinum Chemotherapy Met the Predefined Primary Endpoint in the Phase 3 ORIENT-12 Study as First-Line Therapy in Patients with Locally Advanced or Metastatic Squamous Non-Small Cell Lung Cancer Innovent Biologics, Inc.
06-May-2020 Tyvyt® (Sintilimab Injection) Combined with Gemzar® (Gemcitabine for Injection) and Platinum Chemotherapy Met the Predefined Primary Endpoint in the Phase 3 ORIENT-12 Study as First-Line Therapy in Patients with Locally Advanced or Metastatic Squamous Non-Small Cell Lung Cancer Innovent Biologics, Inc.